Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients.
SourceInternational Journal of Cancer, 66, (1996), pp. 477-483
Article / Letter to editor
Display more detailsDisplay less details
International Journal of Cancer
SubjectTwo-phase radioimmunotherapy with bispecific monoclonal antibodies; Twee-fase radioimmunotherapie met bispecifieke monoclonale antilichamen
This item appears in the following Collection(s)
- Academic publications 
- Faculty of Medical Sciences 
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.